Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.
暂无分享,去创建一个
T. Giese | H. Bujard | W. Haefeli | D. Carter | G. Mikus | A. Blank | M. Lanzer | J. Hüsing | K. Heiss | Anja Jäschke | E. Böhnlein | Kristin Fürle | M. Lehmann